INHIBIKASE
Live / Registered — Registered (as of 14 Jun 2022)
What this means for you
Registered since 14 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88169711
- Registration number
- 6760689
- Mark type
- Stylized text
- Filed
- 25 Oct 2018
- Published for opposition
- 19 Mar 2019
- Registered
- 14 Jun 2022
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: prescription pharmaceuticals to treat neurodegeneration
Owner
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
Prosecution history
- 07 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Jun 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jun 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jun 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jun 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 May 2022 — ASSIGNED TO LIE